Literature DB >> 20303630

Natural radionuclide concentrations in two phosphate ores of east Algeria.

Ch Lakehal1, M Ramdhane, A Boucenna.   

Abstract

Ore is considered as an important source of many elements such as the iron, phosphorus, and uranium. Concerning the natural radionuclides, their concentrations vary from an ore to other depending on the chemical composition of each site. In this work, two phosphate ores found in East of Algeria have been chosen to assess the activity concentration of natural radionuclides represented mainly by three natural radioactive series (238)U, (235)U and (232)Th, and the primordial radionuclide (40)K where they were determined using ultra-low background, high-resolution gamma-ray spectroscopy. The measured activity concentrations of radioactive series ranged from 6.2 +/- 0.4 to 733 +/- 33 Bq.kg(-1) for the (232)Th series, from 249 +/- 16 to 547 +/- 39 Bq.kg(-1) for the (238)U series, around 24.2 +/- 2.5 Bq.kg(-1) for the (235)U series, and from 1.4 +/- 0.2 to 6.7 +/- 0.7 Bq.kg(-1) for (40)K. To assess exposure to gamma radiation in the two ores, from specific activities of (232)Th, (40)K and (226)Ra, three indexes were determined: Radium equivalent (Ra(eq)), external and internal hazard indexes (H(ex) and H(in)), their values ranged from 831 +/- 8 to 1298 +/- 14 Bq.kg(-1) for Ra(eq), from 2.2 +/- 0.4 to 3.5 +/- 0.7 Bq.kg(-1) for H(ex), and from 4.2 +/- 0.7 to 4.5 +/- 0.7 Bq.kg(-1) for H(in). Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303630     DOI: 10.1016/j.jenvrad.2010.02.008

Source DB:  PubMed          Journal:  J Environ Radioact        ISSN: 0265-931X            Impact factor:   2.674


  1 in total

1.  Assessing the Radiological Risks Associated with High Natural Radioactivity of Microgranitic Rocks: A Case Study in a Northeastern Desert of Egypt.

Authors:  Neveen S Abed; Mohamed Abdel Monsif; Hesham M H Zakaly; Hamdy A Awad; Mahmoud M Hessien; Chee Kong Yap
Journal:  Int J Environ Res Public Health       Date:  2022-01-01       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.